211 related articles for article (PubMed ID: 27657809)
1. Targeting telomerase with radiolabeled inhibitors.
Waghorn PA; Jackson MR; Gouverneur V; Vallis KA
Eur J Med Chem; 2017 Jan; 125():117-129. PubMed ID: 27657809
[TBL] [Abstract][Full Text] [Related]
2. Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Morais KDS; Arcanjo DDS; de Faria Lopes GP; da Silva GG; da Mota THA; Gabriel TR; Rabello Ramos DDA; Silva FP; de Oliveira DM
Cell Biochem Funct; 2019 Jun; 37(4):273-280. PubMed ID: 31012504
[TBL] [Abstract][Full Text] [Related]
3. MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
Gurung RL; Lim SN; Low GK; Hande MP
J Nutrigenet Nutrigenomics; 2014; 7(4-6):283-98. PubMed ID: 26022559
[TBL] [Abstract][Full Text] [Related]
4. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
[TBL] [Abstract][Full Text] [Related]
5. Targeting DNA-PKcs and telomerase in brain tumour cells.
Gurung RL; Lim HK; Venkatesan S; Lee PS; Hande MP
Mol Cancer; 2014 Oct; 13():232. PubMed ID: 25307264
[TBL] [Abstract][Full Text] [Related]
6. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
Seimiya H; Oh-hara T; Suzuki T; Naasani I; Shimazaki T; Tsuchiya K; Tsuruo T
Mol Cancer Ther; 2002 Jul; 1(9):657-65. PubMed ID: 12479362
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.
Serrano D; Bleau AM; Fernandez-Garcia I; Fernandez-Marcelo T; Iniesta P; Ortiz-de-Solorzano C; Calvo A
Mol Cancer; 2011 Aug; 10():96. PubMed ID: 21827695
[TBL] [Abstract][Full Text] [Related]
9. Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells.
Andrade da Mota TH; Reis Guimarães AF; Silva de Carvalho AÉ; Saldanha-de Araujo F; Pinto de Faria Lopes G; Pittella-Silva F; do Amaral Rabello D; Madureira de Oliveira D
Tumour Biol; 2021; 43(1):327-340. PubMed ID: 34957975
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitization to X-ray radiation by telomerase inhibitor MST-312 in human hepatoma HepG2 cells.
Wang Y; Sun C; Mao A; Zhang X; Zhou X; Wang Z; Zhang H
Life Sci; 2015 Feb; 123():43-50. PubMed ID: 25596016
[TBL] [Abstract][Full Text] [Related]
11. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
[TBL] [Abstract][Full Text] [Related]
12. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
[TBL] [Abstract][Full Text] [Related]
13. Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment.
Gala K; Jain M; Shah P; Pandey A; Garg M; Khattar E
Life Sci; 2024 Feb; 339():122416. PubMed ID: 38216120
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.
Jackson MR; Bavelaar BM; Waghorn PA; Gill MR; El-Sagheer AH; Brown T; Tarsounas M; Vallis KA
Cancer Res; 2019 Sep; 79(18):4627-4637. PubMed ID: 31311806
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.
Ameri Z; Ghiasi S; Farsinejad A; Hassanshahi G; Ehsan M; Fatemi A
Life Sci; 2019 Jul; 228():66-71. PubMed ID: 31029779
[TBL] [Abstract][Full Text] [Related]
16. Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231.
Konieczna N; Romaniuk-Drapała A; Lisiak N; Totoń E; Paszel-Jaworska A; Kaczmarek M; Rubiś B
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151281
[TBL] [Abstract][Full Text] [Related]
17. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
18. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
20. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
Chen X; Zha GF; Wang JQ; Liu XH
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
